Translation of "Valve chest " (English → French) :

valve chest [ valve box | valve chamber ]

chest type parachute [ lap-pack parachute | chest-type chute | chest parachute | chest chute | chest pack ]

emphysematous chest | barrel-shaped thorax | barrel chest | barrel-shaped chest

head and chest side-impact airbag | head and chest side air bag | seat-mounted head and chest side-impact airbag

chest trap | chest trapping | chest control

body pad (1)(3) | chest guard (2)(3) | chest protector (2)(3)

(9) The cylinders, valve chests and other hot exposed parts of steam engines and steam pipes on a derrick or in a drilling engine room or within 75 feet thereof, whenever the steam temperature exceeds 400°F, shall be fitted with thermal insulation and the insulation shall be covered by metal so that no liquid can be absorbed by the insulating materials.

(7) The pipes from the distribution valve chests to the points of discharge shall be of steel, galvanized inside and outside, or of copper, and suitable for the maximum pressure of the smothering steam; the pipes and outlets shall be kept clear of water and obstructions.

(14) On completion of the pressure test referred to in subsection (13) the inspector shall satisfy himself that all plugs and blank flanges used during the tests have been removed from the distribution system and that all pipes are clear and correctly connected according to the markings on the distribution valve chest.

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...